| Ident. | Authors (with country if any) | Title |
|---|
| 000010 (2020) |
Lisa M. Parsons [États-Unis] ; Yanming An [États-Unis] ; Li Qi [États-Unis] ; Mitchell R. White [États-Unis] ; Roosmarijn Van Der Woude [Pays-Bas] ; Kevan L. Hartshorn [États-Unis] ; Jeffery K. Taubenberger [États-Unis] ; Robert P. De Vries [Pays-Bas] ; John F. Cipollo | Influenza Virus Hemagglutinins H2, H5, H6, and H11 Are Not Targets of Pulmonary Surfactant Protein D: N-Glycan Subtypes in Host-Pathogen Interactions. |
| 000043 (2019) |
Kanta Subbarao | The Critical Interspecies Transmission Barrier at the Animal–Human Interface |
| 000048 (2019) |
Irina Isakova-Sivak [Russie] ; Victoria Matyushenko [Russie] ; Tatiana Kotomina [Russie] ; Irina Kiseleva [Russie] ; Elena Krutikova [Russie] ; Svetlana Donina [Russie] ; Andrey Rekstin [Russie] ; Natalia Larionova [Russie] ; Daria Mezhenskaya [Russie] ; Konstantin Sivak [Russie] ; Arman Muzhikyan [Russie] ; Anastasia Katelnikova [Russie] ; Larisa Rudenko [Russie] | Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge |
| 000061 (2019) |
Judith Del Campo [France] ; Andres Pizzorno ; Sophia Djebali [France] ; Julien Bouley [France] ; Marjorie Haller [France] ; Jimena Pérez-Vargas [France] ; Bruno Lina [France] ; Guy Boivin [Canada] ; Marie-Eve Hamelin [Canada] ; Florence Nicolas [France] ; Alexandre Le Vert [France] ; Yann Leverrier [France] ; Manuel Rosa-Calatrava ; Jacqueline Marvel [France] ; Fergal Hill [France] | OVX836 a recombinant nucleoprotein vaccine inducing cellular responses and protective efficacy against multiple influenza A subtypes |
| 000066 (2019) |
Chavely Gwladys Monamele [Cameroun] ; Hermann Landry Munshili Njifon [Cameroun] ; Marie-Astrid Vernet [Cameroun] ; Mohamadou Ripa Njankouo [Cameroun] ; Sebastien Kenmoe [Cameroun] ; Ali Ahmed Yahaya ; Louis Deweerdt [Cameroun] ; Raphael Nono [Cameroun] ; Wilfred Mbacham [Cameroun] ; Damian Nota Anong [Cameroun] ; Jane Francis Akoachere [Cameroun] ; Richard Njouom [Cameroun] | Molecular characterization of influenza A(H1N1)pdm09 in Cameroon during the 2014-2016 influenza seasons |
| 000091 (2019) |
Mohamed A. Farrag [Arabie saoudite] ; Maaweya E. Hamed [Arabie saoudite] ; Haitham M. Amer [Égypte] ; Fahad N. Almajhdi [Arabie saoudite] | Epidemiology of respiratory viruses in Saudi Arabia: toward a complete picture |
| 000157 (2018) |
Giulia Fabozzi [États-Unis] ; Andrew J. Oler [États-Unis] ; Poching Liu [États-Unis] ; Yong Chen [États-Unis] ; Samuel Mindaye [États-Unis] ; Michael A. Dolan [États-Unis] ; Heather Kenney [États-Unis] ; Marjan Gucek [États-Unis] ; Jun Zhu [États-Unis] ; Ronald L. Rabin [États-Unis] ; Kanta Subbarao [États-Unis] | Strand-Specific Dual RNA Sequencing of Bronchial Epithelial Cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions |
| 000193 (2018) |
Chun-Yeung Lo ; Olive Tin-Wai Li ; Wen-Ping Tang [République populaire de Chine] ; Chun Hu [République populaire de Chine] ; Guo Xin Wang [République populaire de Chine] ; Jacky Chi-Ki Ngo ; David Chi-Cheong Wan ; Leo Lit-Man Poon ; Pang-Chui Shaw | Identification of influenza polymerase inhibitors targeting C-terminal domain of PA through surface plasmon resonance screening |
| 000194 (2018) |
Stéphane Pillet ; Éric Aubin ; Sonia Trépanier ; Jean-François Poulin ; Bader Yassine-Diab ; Jan Ter Meulen [États-Unis] ; Brian J. Ward ; Nathalie Landry | Humoral and cell-mediated immune responses to H5N1 plant-made virus-like particle vaccine are differentially impacted by alum and GLA-SE adjuvants in a Phase 2 clinical trial |
| 000199 (2018) |
Ya-Fang Wang [Taïwan] ; Chuan-Fa Chang [Taïwan] ; Huey-Pin Tsai [Taïwan] ; Chia-Yu Chi [Taïwan] ; Ih-Jen Su [Taïwan] ; Jen-Ren Wang [Taïwan] | Glycan-binding preferences and genetic evolution of human seasonal influenza A(H3N2) viruses during 1999-2007 in Taiwan |
| 000200 (2018) |
Lan Xue [République populaire de Chine] ; Guang Zeng [République populaire de Chine] | Global Strategies and Response Measures to the Influenza A (H1N1) Pandemic |
| 000212 (2018) |
Liudmila M. Tsybalova [Russie] ; Liudmila A. Stepanova [Russie] ; Marina A. Shuklina [Russie] ; Eugenia S. Mardanova [Russie] ; Roman Y. Kotlyarov [Russie] ; Marina V. Potapchuk [Russie] ; Sergei A. Petrov [Russie] ; Elena A. Blokhina [Russie] ; Nikolai V. Ravin [Russie] | Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine. |
| 000216 (2018) |
Jiong Wang [États-Unis] ; Shannon P. Hilchey [États-Unis] ; Marta Dediego [États-Unis] ; Sheldon Perry [États-Unis] ; Ollivier Hyrien [États-Unis] ; Aitor Nogales [États-Unis] ; Jessica Garigen [États-Unis] ; Fatima Amanat [États-Unis] ; Nelson Huertas [États-Unis] ; Florian Krammer [États-Unis] ; Luis Martinez-Sobrido [États-Unis] ; David J. Topham [États-Unis] ; John J. Treanor [États-Unis] ; Mark Y. Sangster [États-Unis] ; Martin S. Zand [États-Unis] | Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice |
| 000254 (2017) |
Amandine Brochot [France] ; Angèle Guilbot [France] ; Laïla Haddioui [France] ; Christine Roques [France] | Antibacterial, antifungal, and antiviral effects of three essential oil blends |
| 000255 (2017) |
Helena Grgi [Canada] ; Jackie Gallant ; Zvonimir Poljak [Canada] | Virological Surveillance of Influenza A Subtypes Isolated in 2014 from Clinical Outbreaks in Canadian Swine |
| 000259 (2017) |
Robert P. De Vries [États-Unis, Pays-Bas] ; Wenjie Peng [États-Unis] ; Oliver C. Grant [États-Unis] ; Andrew J. Thompson [États-Unis] ; Xueyong Zhu [États-Unis] ; Kim M. Bouwman [Pays-Bas] ; Alba T. Torrents De La Pena [Pays-Bas] ; Marielle J. Van Breemen [Pays-Bas] ; Iresha N. Ambepitiya Wickramasinghe [Pays-Bas] ; Cornelis A. M. De Haan [Pays-Bas] ; Wenli Yu [États-Unis] ; Ryan Mcbride [États-Unis] ; Rogier W. Sanders [Pays-Bas, États-Unis] ; Robert J. Woods [États-Unis] ; Monique H. Verheije [Pays-Bas] ; Ian A. Wilson [États-Unis] ; James C. Paulson [États-Unis] | Three mutations switch H7N9 influenza to human-type receptor specificity |
| 000264 (2017) |
Nicholas Wohlgemuth [États-Unis] ; Yang Ye [États-Unis] ; Katherine J. Fenstermacher [États-Unis] ; Hsuan Liu [États-Unis] ; Andrew P. Lane [États-Unis] ; Andrew Pekosz [États-Unis] | The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells. |
| 000301 (2017) |
Jiejian Luo [République populaire de Chine] ; Lizong Deng [République populaire de Chine] ; Xiao Ding [République populaire de Chine] ; Lijun Quan [République populaire de Chine] ; Aiping Wu [République populaire de Chine] ; Taijiao Jiang [République populaire de Chine] | Hydrogen Bond Variations of Influenza A Viruses During Adaptation in Human |
| 000306 (2017) |
Ivan Sanz [Espagne] ; Silvia Rojo [Espagne] ; Sonia Tamames ; José María Eiros [Espagne] ; Raúl Ortiz De Lejarazu [Espagne] | Heterologous Humoral Response against H5N1, H7N3, and H9N2 Avian Influenza Viruses after Seasonal Vaccination in a European Elderly Population |
| 000308 (2017) |
Marion Russier [États-Unis] ; Guohua Yang [États-Unis] ; Atanaska Marinova-Petkova [États-Unis] ; Peter Vogel [États-Unis] ; Bryan S. Kaplan [États-Unis] ; Richard J. Webby [États-Unis] ; Charles J. Russell [États-Unis] | H1N1 influenza viruses varying widely in hemagglutinin stability transmit efficiently from swine to swine and to ferrets |
| 000311 (2017) |
Gwladys C. Monamele [Cameroun] ; Marie-Astrid Vernet [Cameroun] ; Mohammed R. Njankouo [Cameroun] ; Kathleen Victoir [France] ; Jane Francis Akoachere [Cameroun] ; Damian Anong [Cameroun] ; Richard Njouom [Cameroun] | Genetic and antigenic characterization of influenza A(H3N2) in Cameroon during the 2014-2016 influenza seasons |
